A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma

Cisplatin-based concurrent chemoradiotherapy for patients with unresectable, locally advanced esophageal squamous cell carcinoma (ESCC) is associated with significant toxicities that are often intolerable. Prognosis for this subgroup of patients remains poor, and new therapeutic approaches are urgen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhao, Chuanhua, Lin, Li, Liu, Jianzhi, Liu, Rongrui, Chen, Yuling, Ge, Feijiao, Jia, Ru, Jin, Yang, Wang, Yan, Xu, Jianming
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302991/
https://ncbi.nlm.nih.gov/pubmed/28087951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9809
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados